Relapse after treatment with standardized all-oral short regimens for rifampicin-resistant tuberculosis (RR-TB): A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Relapse after treatment with standardized all-oral short regimens for rifampicin-resistant tuberculosis (RR-TB): A systematic review and meta-analysis

Published:2024-05 Issue: Volume:35 Page:100426
ISSN:2405-5794
Container-title:Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
language:en
Short-container-title:Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

Author:

Reza Yosofi Ahmad,Mesic Anita,Decroo Tom

Publisher

Elsevier BV

Reference46 articles.

1. Global tuberculosis report 2023 [Internet]. Who.int. [cited 2024 Jan 22]. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023.

2. Prevalence of rifampicin resistant tuberculosis among pulmonary tuberculosis patients In Enugu, Nigeria;Ulasi;Afr Health Sci [Internet],2022

3. Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen;Jo;Respir Med,2014

4. Clinically encountered growth phenotypes of tuberculosis-causing bacilli and their in vitro study: A review;Mishra;Front Cell Infect Microbiol [Internet],2022

5. Principles for constructing a tuberculosis treatment regimen: the role and definition of core and companion drugs;Van Deun;Int J Tuberc Lung Dis [Internet],2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP